Efficacy and Safety of Bevacizumab in the First-Line Treatment of Advanced Driver-Gene Negative Lung Adenocarcinoma
DING Ruoying
HU Wei
LIU Kuiyuan
LIU Jingeng
CHENG Mingzhen
Machine-generated Keywords:
Publication Date:2023-02-15
Online Publishing Date:2026-09-12(First online date of this platform, not the publication date of the document)
Pages:6( 442-447 )
